Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind, randomized, placebo-controlled cross-over trial of levetiracetam in paediatric Tourette syndrome
2005-002041-40Phase 4Active
- Sponsor
- Sant Joan de Déu Hospital
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levetiracetam in Tourette syndrome (TS) (2 arms), sponsored by Sant Joan de Déu Hospital. Primary endpoint: Control of motor and phonic tics. Started Oct 2005; status: active.
02
Drugs
levetiracetam
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on 2005-002041-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002041-40.